DrugPatentWatch Database Preview
« Back to Dashboard
Summary for Patent: 5,472,969
|Title:||Method of inhibiting glycolipid synthesis|
|Abstract:||A method is disclosed for inhibiting the biosynthesis of glycolipids in cells capable of producing glycolipids comprising subjecting said cells to a glycolipid inhibitory effective amount of an N-alkyl derivative of 1,5-dideoxy-1,5-imino-D-glucitol in which said alkyl contains from 2-8 carbon atoms.|
|Inventor(s):||Platt; Frances M. (Oxford, GB), Neises; Gabrielle R. (Chesterfield, MO), Dwek; Raymond A. (Oxford, GB), Butters; Terry D. (Oxford, GB)|
|Assignee:||Monsanto Company (St. Louis, MO)|
1. The method of treating a patient affected with Gaucher's disease comprising administering to said patient a glycolipid inhibitory effective amount of an N-alkyl derivative
of 1,5-dideoxy-1,5-imino-D-glucitol in which said alky contains from 2-8 carbon atoms.
2. The method of claim 1 in which the alkyl group containing form 4-6 carbon atoms.
3. The method of claim 2 in which the alkyl group is butyl.
4. The method of claim 2 in which the alkyl group is hexyl.
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally: